<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.gutpathogens.com/feeds/mostaccessed/journal?quantity=&amp;format=rss&amp;version=">
        <title>Gut Pathogens - Most accessed articles</title>
        <link>http://www.gutpathogens.com</link>
        <description>The most accessed research articles published by Gut Pathogens</description>
        <dc:date>2009-12-23T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.gutpathogens.com/content/1/1/16" />
                                <rdf:li rdf:resource="http://www.gutpathogens.com/content/1/1/19" />
                                <rdf:li rdf:resource="http://www.gutpathogens.com/content/1/1/21" />
                                <rdf:li rdf:resource="http://www.gutpathogens.com/content/1/1/8" />
                                <rdf:li rdf:resource="http://www.gutpathogens.com/content/1/1/15" />
                                <rdf:li rdf:resource="http://www.gutpathogens.com/content/1/1/6" />
                                <rdf:li rdf:resource="http://www.gutpathogens.com/content/1/1/22" />
                                <rdf:li rdf:resource="http://www.gutpathogens.com/content/1/1/24" />
                                <rdf:li rdf:resource="http://www.gutpathogens.com/content/1/1/14" />
                                <rdf:li rdf:resource="http://www.gutpathogens.com/content/1/1/17" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.gutpathogens.com/content/1/1/16">
        <title>The case for biocentric microbiology</title>
        <description>Microbiology is a relatively modern scientific discipline intended to objectively study microorganisms, including pathogens and nonpathogens. However, since its birth, this science has been negatively affected by anthropocentric convictions, including rational and irrational beliefs. Among these, for example, is the artificial separation between environmental and medical microbiology that weakens both disciplines. Anthropocentric microbiology also fails to properly answer questions concerning the evolution of microbial pathogenesis. Here, I argue that an exclusively biocentric microbiology is imperative for improving our understanding not only of the microbial world, but also of our own species, our guts, and the world around us.</description>
        <link>http://www.gutpathogens.com/content/1/1/16</link>
                <dc:creator>Ramy Aziz</dc:creator>
                <dc:source>Gut Pathogens 2009, 1:16</dc:source>
        <dc:date>2009-08-04T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1757-4749-1-16</dc:identifier>
        <prism:publicationName>Gut Pathogens</prism:publicationName>
        <prism:issn>1757-4749</prism:issn>
        <prism:volume>1</prism:volume>
        <prism:startingPage>16</prism:startingPage>
        <prism:publicationDate>2009-08-04T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.gutpathogens.com/content/1/1/19">
        <title>Probiotics and gastrointestinal disease: successes, problems and future prospects</title>
        <description>Gastrointestinal disease is a major cause of morbidity and mortality worldwide each year. Treatment of chronic inflammatory gastrointestinal conditions such as ulcerative colitis and Crohn&apos;s disease is difficult due to the ambiguity surrounding their precise aetiology. Infectious gastrointestinal diseases, such as various types of diarrheal disease are also becoming increasingly difficult to treat due to the increasing dissemination of antibiotic resistance among microorganisms and the emergence of the so-called &apos;superbugs&apos;. Taking into consideration these problems, the need for novel therapeutics is essential. Although described for over a century probiotics have only been extensively researched in recent years. Their use in the treatment and prevention of disease, particularly gastrointestinal disease, has yielded many successful results, some of which we outline in this review. Although promising, many probiotics are hindered by inherent physiological and technological weaknesses and often the most clinically promising strains are unusable. Consequently we discuss various strategies whereby probiotics may be engineered to create designer probiotics. Such innovative approaches include; a receptor mimicry strategy to create probiotics that target specific pathogens and toxins, a patho-biotechnology approach using pathogen-derived genes to create more robust probiotic stains with increased host and processing-associated stress tolerance profiles and meta-biotechnology, whereby, functional metagenomics may be used to identify novel genes from diverse and vastly unexplored environments, such as the human gut, for use in biotechnology and medicine.</description>
        <link>http://www.gutpathogens.com/content/1/1/19</link>
                <dc:creator>Eamonn Culligan</dc:creator>
                <dc:creator>Colin Hill</dc:creator>
                <dc:creator>Roy Sleator</dc:creator>
                <dc:source>Gut Pathogens 2009, 1:19</dc:source>
        <dc:date>2009-11-23T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1757-4749-1-19</dc:identifier>
        <prism:publicationName>Gut Pathogens</prism:publicationName>
        <prism:issn>1757-4749</prism:issn>
        <prism:volume>1</prism:volume>
        <prism:startingPage>19</prism:startingPage>
        <prism:publicationDate>2009-11-23T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.gutpathogens.com/content/1/1/21">
        <title>A hundred-year-old insight into the gut microbiome!</title>
        <description>As the National Institutes of Health-funded Human Microbiome Project enters its second phase, and as a major part of this project focuses on the human gut microbiome and its effects on human health, it might help us to travel a century back in time and examine how microbiologists dealt with microbiome-related challenges similar to those of the 21st century using the tools of their time. An article by Arthur I. Kendall, published in The Journal of Biological Chemistry in November 1909 (Some observations on the study of the intestinal bacteria J Biol Chem 1909, 6:499-507), offers a visionary insight into many of today&apos;s hot research questions.</description>
        <link>http://www.gutpathogens.com/content/1/1/21</link>
                <dc:creator>Ramy Karam Aziz</dc:creator>
                <dc:source>Gut Pathogens 2009, 1:21</dc:source>
        <dc:date>2009-12-07T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1757-4749-1-21</dc:identifier>
        <prism:publicationName>Gut Pathogens</prism:publicationName>
        <prism:issn>1757-4749</prism:issn>
        <prism:volume>1</prism:volume>
        <prism:startingPage>21</prism:startingPage>
        <prism:publicationDate>2009-12-07T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.gutpathogens.com/content/1/1/8">
        <title>Lactobacillus delbrueckii ssp. bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cells</title>
        <description>Background:
Probiotic microorganisms are receiving increasing interest for use in the prevention, treatment, or dietary management of certain diseases, including antibiotic-associated diarrhea (AAD). Clostridium difficile is the most common cause of AAD and the resulting C. difficile &#8211; mediated infection (CDI), is potentially deadly. C. difficile associated diarrhea (CDAD) is manifested by severe inflammation and colitis, mostly due to the release of two exotoxins by C. difficile causing destruction of epithelial cells in the intestine. The aim of this study was to determine the effect of probiotic bacteria Lactobacillus delbrueckii ssp. bulgaricus B-30892 (LDB B-30892) on C. difficile-mediated cytotoxicity using Caco-2 cells as a model.
Methods:
Experiments were carried out to test if the cytotoxicity induced by C. difficile-conditioned-medium on Caco-2 cells can be altered by cell-free supernatant (CFS) from LDB B-30892 in different dilutions (1:2 to 1:2048). In a similar experimental setup, comparative evaluations of other probiotic strains were made by contrasting the results from these strains with the results from LDB B-30892, specifically the ability to affect C. difficile induced cytotoxicity on Caco-2 monolayers. Adhesion assays followed by quantitative analysis by Giemsa staining were conducted to test if the CFSs from LDB B-30892 and other probiotic test strains have the capability to alter the adhesion of C. difficile to the Caco-2 monolayer. Experiments were also performed to evaluate if LDB B-30892 or its released components have any bactericidal effect on C. difficile.Results and discussionCo-culturing of LDB B-30892 with C. difficile inhibited the C. difficile-mediated cytotoxicity on Caco-2 cells. When CFS from LDB B-30892-C. difficile co-culture was administered (up to a dilution of 1:16) on Caco-2 monolayer, there were no signs of cytotoxicity. When CFS from separately grown LDB B-30892 was mixed with the cell-free toxin preparation (CFT) of separately cultured C. difficile, the LDB B-30892 CFS was inhibitory to C. difficile CFT-mediated cytotoxicity at a ratio of 1:8 (LDB B-30892 CFS:C. difficile CFT). We failed to find any similar inhibition of C. difficile-mediated cytotoxicity when other probiotic organisms were tested in parallel to LDB B-30892. Our data of cytotoxicity experiments suggest that LDB B-30892 releases one or more bioactive component(s) into the CFS, which neutralizes the cytotoxicity induced by C. difficile, probably by inactivating its toxin(s). Our data also indicate that CFS from LDB B-30892 reduced the adhesion of C. difficile by 81%, which is significantly (P &lt;0.01) higher than all other probiotic organisms tested in this study.
Conclusion:
This study reveals the very first findings that Lactobacillus delbrueckii ssp. bulgaricus B-30892 (LDB B-30892) can eliminate C. difficile-mediated cytotoxicity, using Caco-2 cells as a model. The study also demonstrates that LDB B-30892 can reduce the colonization of C. difficile cells in colorectal cells. More study is warranted to elucidate the specific mechanism of action of such reduction of cytotoxicity and colonization.</description>
        <link>http://www.gutpathogens.com/content/1/1/8</link>
                <dc:creator>Pratik Banerjee</dc:creator>
                <dc:creator>Glenn Merkel</dc:creator>
                <dc:creator>Arun Bhunia</dc:creator>
                <dc:source>Gut Pathogens 2009, 1:8</dc:source>
        <dc:date>2009-04-27T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1757-4749-1-8</dc:identifier>
        <prism:publicationName>Gut Pathogens</prism:publicationName>
        <prism:issn>1757-4749</prism:issn>
        <prism:volume>1</prism:volume>
        <prism:startingPage>8</prism:startingPage>
        <prism:publicationDate>2009-04-27T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.gutpathogens.com/content/1/1/15">
        <title>Mycobacterium avium subspecies paratuberculosis, Crohn&apos;s disease 
and the Doomsday Scenario
</title>
        <description>Johne&apos;s disease is chronic inflammation of the intestine caused by Mycobacterium avium subspecies paratuberculosis. Infection and disease are mainly in domestic livestock but can affect many species including primates. Johne&apos;s is a new disease which emerged at the turn of the 19th and 20th centuries and principally involved Europe and North America. It has since spread to former low incidence regions to become a global problem. Crohn&apos;s disease is a chronic inflammation of the intestine in humans which emerged in Europe and North America mid 20th century and increased to become a major healthcare problem. It has now spread to former low incidence regions. Infected animals shed Mycobacterium avium subspecies paratuberculosis in milk and into the environment. Human populations are widely exposed. Outcomes maybe influenced by microbial phenotype. Exposure to extracellular forms of these pathogens may confer some natural protection; exposure to intracellular forms which have passaged through milk macrophages or environmental protists may pose a greater threat to humans particularly individuals with an inherited or acquired susceptibility. Hot spots of human disease such as in Winnipeg which sits on rock at the junction of two rivers may result from local exposure to high levels of waterborne pathogens brought down from farmland. When appropriate methods are used most people with Crohn&apos;s disease are found to be infected. There are no data which demonstrate that these pathogens are harmless to humans. An overwhelming balance of probability and Public health risk favours the conclusion that Mycobacterium avium subspecies paratuberculosis is also pathogenic for people. A two tier co-operative pathogenic mechanism is proposed in Crohn&apos;s disease. Intracellular infection with the primary pathogen widely distributed throughout the gut causes an immune dysregulation and a specific chronic enteric neuropathy with loss of mucosal integrity. Segments of gross inflammatory disease result from the perturbed neuroimmune response to penetration into the gut wall of secondary pathogens from the lumen. These include both normal gut organisms and educated members of the enteric microbiome such as more aggressive E. coli. More new diseases may arise from failure to apply a range of remedial measures to this longstanding zoonotic problem.</description>
        <link>http://www.gutpathogens.com/content/1/1/15</link>
                <dc:creator>John Hermon-Taylor</dc:creator>
                <dc:source>Gut Pathogens 2009, 1:15</dc:source>
        <dc:date>2009-07-14T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1757-4749-1-15</dc:identifier>
        <prism:publicationName>Gut Pathogens</prism:publicationName>
        <prism:issn>1757-4749</prism:issn>
        <prism:volume>1</prism:volume>
        <prism:startingPage>15</prism:startingPage>
        <prism:publicationDate>2009-07-14T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.gutpathogens.com/content/1/1/6">
        <title>A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome.</title>
        <description>Chronic fatigue syndrome (CFS) is complex illness of unknown etiology. Among the broad range of symptoms, many patients report disturbances in the emotional realm, the most frequent of which is anxiety. Research shows that patients with CFS and other so-called functional somatic disorders have alterations in the intestinal microbial flora. Emerging studies have suggested that pathogenic and non-pathogenic gut bacteria might influence mood-related symptoms and even behavior in animals and humans. In this pilot study, 39 CFS patients were randomized to receive either 24 billion colony forming units of Lactobacillus casei strain Shirota (LcS) or a placebo daily for two months. Patients provided stool samples and completed the Beck Depression and Beck Anxiety Inventories before and after the intervention. We found a significant rise in both Lactobacillus and Bifidobacteria in those taking the LcS, and there was also a significant decrease in anxiety symptoms among those taking the probiotic vs controls (p = 0.01). These results lend further support to the presence of a gut-brain interface, one that may be mediated by microbes that reside or pass through the intestinal tract.</description>
        <link>http://www.gutpathogens.com/content/1/1/6</link>
                <dc:creator>A Venket Rao</dc:creator>
                <dc:creator>Alison Bested</dc:creator>
                <dc:creator>Tracey Beaulne</dc:creator>
                <dc:creator>Martin Katzman</dc:creator>
                <dc:creator>Christina Iorio</dc:creator>
                <dc:creator>John Berardi</dc:creator>
                <dc:creator>Alan Logan</dc:creator>
                <dc:source>Gut Pathogens 2009, 1:6</dc:source>
        <dc:date>2009-03-19T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1757-4749-1-6</dc:identifier>
        <prism:publicationName>Gut Pathogens</prism:publicationName>
        <prism:issn>1757-4749</prism:issn>
        <prism:volume>1</prism:volume>
        <prism:startingPage>6</prism:startingPage>
        <prism:publicationDate>2009-03-19T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.gutpathogens.com/content/1/1/22">
        <title>Adhesive threads of extraintestinal pathogenic Escherichia coli</title>
        <description>The ability to adhere to host surfaces is by far the most vital step in the successful colonization by microbial pathogens. Colonization begins with the attachment of the bacterium to receptors expressed by cells forming the lining of the mucosa. Long hair like extracellular appendages called fimbriae, produced by most Gram-negative pathogens, mediate specific attachment to the epithelial cell surface. Associated with the fimbriae is a protein called an adhesin, which directs high-affinity binding to specific cell surface components. In the last couple of years, an enormous amount of research has been undertaken that deals with understanding how bacterial pathogens adhere to host cells. E. coli in all probability is one of the best studied free-living organisms. A group of E. coli called Extraintestinal pathogenic E. coli (ExPEC) including both human and animal pathogens like Uropathogenic E. coli (UPEC), Newborn meningitic E. coli (NMEC) and Avian pathogenic E. coli (APEC), have been found to harbour many fimbriae including Type 1 fimbriae, P fimbriae, curli fibres, S fimbriae, F1C fimbriae, Dr fimbriae, afimbrial adhesins, temperature-sensitive haemagglutinin and many novel adhesin gene clusters that have not yet been characterized. Each of these adhesins is unique due to the recognition of an adhesin-specific receptor, though as a group these adhesins share common genomic organization. A newly identified putative adhesin temporarily termed ExPEC Adhesin I, encoded by gene yqi, has been recently found to play a significant role in the pathogenesis of APEC infection, thus making it an interesting candidate for future research. The aim of this review is to describe the role of ExPEC adhesins during extraintestinal infections known till date, and to suggest the idea of investigating their potential role in the colonization of the host gut which is said to be a reservoir for ExPEC.</description>
        <link>http://www.gutpathogens.com/content/1/1/22</link>
                <dc:creator>Esther-Maria Antao</dc:creator>
                <dc:creator>Lothar Wieler</dc:creator>
                <dc:creator>Christa Ewers</dc:creator>
                <dc:source>Gut Pathogens 2009, 1:22</dc:source>
        <dc:date>2009-12-10T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1757-4749-1-22</dc:identifier>
        <prism:publicationName>Gut Pathogens</prism:publicationName>
        <prism:issn>1757-4749</prism:issn>
        <prism:volume>1</prism:volume>
        <prism:startingPage>22</prism:startingPage>
        <prism:publicationDate>2009-12-10T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.gutpathogens.com/content/1/1/24">
        <title>Helicobacter pylori - a seasoned pathogen by any other name</title>
        <description>Helicobacter pylori is a well known inhabitant of human stomach which is linked to peptic ulcer disease and gastric adenocarcinoma. It was recently shown in several studies that H. pylori can be harnessed as a surrogate marker of human migration and that its population structure and stratification patterns exactly juxtapose to those of Homo sapiens. This is enough a testimony to convey that H. pylori may have coevolved with their host. Several protective effects of H. pylori colonization have been considered as evidence of a presumed symbiotic relationship. Contrary to this assumption is the presence of a strong virulence apparatus within H. pylori; why a co-evolved parasite would try inflicting its host with serious infection and even causing cancer? The answer is perhaps embedded in the evolutionary history of both the bacterium and the host. We discuss a hypothetical scenario wherein H. pylori may have acquired virulence genes from donors within its environment that varied with change in human history and ecology. The H. pylori genomes sequenced to date portray fairly high abundance of such laterally acquired genes which have no assigned functions but could be linked to inflammatory responses or other pathogenic attributes. Therefore, the powerful virulence properties and survival strategies of Helicobacter make it a seasoned pathogen; thus the efforts to portray it as a commensal or a (harmless) &apos;bacterial parasite&apos; need rethinking.</description>
        <link>http://www.gutpathogens.com/content/1/1/24</link>
                <dc:creator>Niyaz Ahmed</dc:creator>
                <dc:creator>Shivendra Tenguria</dc:creator>
                <dc:creator>Nishant Nandanwar</dc:creator>
                <dc:source>Gut Pathogens 2009, 1:24</dc:source>
        <dc:date>2009-12-23T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1757-4749-1-24</dc:identifier>
        <prism:publicationName>Gut Pathogens</prism:publicationName>
        <prism:issn>1757-4749</prism:issn>
        <prism:volume>1</prism:volume>
        <prism:startingPage>24</prism:startingPage>
        <prism:publicationDate>2009-12-23T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.gutpathogens.com/content/1/1/14">
        <title>Salmonella enterica serovar Typhimurium adhesion and cytotoxicity during epithelial cell stress is reduced by Lactobacillus rhamnosus GG</title>
        <description>Background:
Physiological stressors may alter susceptibility of the host intestinal epithelium to infection by enteric pathogens. In the current study, cytotoxic effect, adhesion and invasion of Salmonella enterica serovar Typhimurium (S. Typhimurium) to Caco-2 cells exposed to thermal stress (41&#176;C, 1 h) was investigated. Probiotic bacteria have been shown to reduce interaction of pathogens with the epithelium under non-stress conditions and may have a significant effect on epithelial viability during infection; however, probiotic effect on pathogen interaction with epithelial cells under physiological stress is not known. Therefore, we investigated the influence of Lactobacillus rhamnosus GG and Lactobacillus gasseri on Salmonella adhesion and Salmonella-induced cytotoxicity of Caco-2 cells subjected to thermal stress.
Results:
Thermal stress increased the cytotoxic effect of both S. Typhimurium (P = 0.0001) and nonpathogenic E. coli K12 (P = 0.004) to Caco-2 cells, and resulted in greater susceptibility of cell monolayers to S. Typhimurium adhesion (P = 0.001). Thermal stress had no significant impact on inflammatory cytokines released by Caco-2 cells, although exposure to S. Typhimurium resulted in greater than 80% increase in production of IL-6 and IL-8. Blocking S. Typhimurium with anti-ShdA antibody prior to exposure of Salmonella decreased adhesion (P = 0.01) to non-stressed and thermal-stressed Caco-2 cells. Pre-exposure of Caco-2 cells to L. rhamnosus GG significantly reduced Salmonella-induced cytotoxicity (P = 0.001) and Salmonella adhesion (P = 0.001) to Caco-2 cells during thermal stress, while L. gasseri had no effect.
Conclusion:
Results suggest that thermal stress increases susceptibility of intestinal epithelial Caco-2 cells to Salmonella adhesion, and increases the cytotoxic effect of Salmonella during infection. Use of L. rhamnosus GG as a probiotic may reduce the severity of infection during epithelial cell stress. Mechanisms by which thermal stress increases susceptibility to S. Typhimurium colonization and by which L. rhamnosus GG limits the severity of infection remain to be elucidated.</description>
        <link>http://www.gutpathogens.com/content/1/1/14</link>
                <dc:creator>Kristin Burkholder</dc:creator>
                <dc:creator>Arun Bhunia</dc:creator>
                <dc:source>Gut Pathogens 2009, 1:14</dc:source>
        <dc:date>2009-07-09T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1757-4749-1-14</dc:identifier>
        <prism:publicationName>Gut Pathogens</prism:publicationName>
        <prism:issn>1757-4749</prism:issn>
        <prism:volume>1</prism:volume>
        <prism:startingPage>14</prism:startingPage>
        <prism:publicationDate>2009-07-09T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.gutpathogens.com/content/1/1/17">
        <title>Possible Transmission of Mycobacterium avium subspecies paratuberculosis through Potable Water: Lessons from an Urban Cluster of Crohn&apos;s Disease</title>
        <description>A &quot;cluster&quot; of patients refers to the geographic proximity of unrelated patients with the same disease and suggests a common environmental cause for that disease. Clusters of patients with Crohn&apos;s disease have been linked to the presence of an infectious microorganism in unpasteurized milk and cheese, untreated water supplied by wells or springs, animal manure used as fertilizer for family vegetable gardens, and bodies of water contaminated by agricultural runoff.Mycobacterium avium subspecies paratuberculosis (MAP) is the suspected cause of Crohn&apos;s disease. MAP causes a disease in dairy cows and other animals that is similar to Crohn&apos;s disease, called Johne&apos;s (&apos;Yo-knees&apos;) disease or paratuberculosis. Dairy cows with Johne&apos;s disease secrete MAP into their milk and excrete MAP into their feces. MAP is present in untreated water such as well water, in bodies of water contaminated by agricultural runoff, and in unpasteurized milk and cheese.The &quot;treatment&quot; of &quot;tap&quot; water to make it &quot;drinkable&quot; or &quot;potable&quot; by the processes of sedimentation, filtration and chlorination has little to no effect on MAP. MAP is so resistant to chlorine disinfection that such disinfection actually selects for its growth. Other subspecies of Mycobacterium avium grow in biofilms present on tap water pipes. Despite the documented presence of MAP in tap water and its probable growth on tap water pipes, clusters of Crohn&apos;s disease have not previously been described in relationship to tap water pipes supplying patients&apos; homes.This report describes three unrelated individuals who lived on the same block along a street in a midwestern American city and developed Crohn&apos;s disease within four years of each other in the 1960&apos;s. A common tap water pipe supplied their homes.This is the first reported cluster of Crohn&apos;s disease possibly linked to fully treated drinking water, and is consistent with previously reported clusters of Crohn&apos;s disease linked to an infectious microorganism in water.</description>
        <link>http://www.gutpathogens.com/content/1/1/17</link>
                <dc:creator>Ellen Pierce</dc:creator>
                <dc:source>Gut Pathogens 2009, 1:17</dc:source>
        <dc:date>2009-09-23T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1757-4749-1-17</dc:identifier>
        <prism:publicationName>Gut Pathogens</prism:publicationName>
        <prism:issn>1757-4749</prism:issn>
        <prism:volume>1</prism:volume>
        <prism:startingPage>17</prism:startingPage>
        <prism:publicationDate>2009-09-23T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
